Gut Microbiota and Antibiotics - Prevention of Side Effects by New Prebiotics

Gut Microbiota and Antibiotics - Prevention of Side Effects by New Prebiotics

Antibiotics disturb the balance of gut microbiota causing dysbiosis. The purpose of this double-blind placebo controlled intervention study is to investigate whether a new prebiotic product could prevent the side effects of antibiotics.

Thirty children (2-6 years of age), who require antibiotic treatment assessed by a doctor, will be enrolled in the study. The children will be randomized to receive either the prebiotic product or placebo during the course of antibiotic treatment.

The children will give a faecal sample in the beginning and at the end of the study. The samples will be used for the analysis of microbiota and differences in the microbiota between the groups.

Inclusion Criteria:

• An infection requiring antibiotic treatment assessed by a doctor

Exclusion Criteria:

• Coaeliac disease or allergy to cereals, use of other prebiotic/probiotic product during the study